The use of prescription drugs and health care services during the 6-month post-COVID-19 period
- PMID: 37468497
- PMCID: PMC10356787
- DOI: 10.1038/s41598-023-38691-9
The use of prescription drugs and health care services during the 6-month post-COVID-19 period
Abstract
COVID-19 and other acute respiratory viruses can have a long-term impact on health. We aimed to assess the common features and differences in the post-acute phase of COVID-19 compared with other non-chronic respiratory infections (RESP) using population-based electronic health data. We applied the self-controlled case series method where prescription drugs and health care utilisation were used as indicators of health outcomes during the six-month-long post-acute period. The incidence rate ratios of COVID-19 and RESP groups were compared. The analysis included 146 314 individuals. Out of 5452 drugs analysed, 14 had increased administration after COVID-19 with drugs for cardiovascular diseases (trimetazidine, metoprolol, rosuvastatin) and psychotropic drugs (alprazolam, zolpidem, melatonin) being most prevalent. The health impact of COVID-19 was more apparent among females and individuals with non-severe COVID-19. The increased risk of exacerbating pre-existing conditions was observed for the COVID-19 group. COVID-19 vaccination did not have effect on drug prescriptions but lowered the health care utilisation during post-acute period. Compared with RESP, COVID-19 increased the use of outpatient services during the post-infection period. The long-term negative impact of COVID-19 on life quality must be acknowledged, and supportive health care and public health services provided.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study.BMJ Open. 2024 Jan 4;14(1):e070031. doi: 10.1136/bmjopen-2022-070031. BMJ Open. 2024. PMID: 38176877 Free PMC article.
-
Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves.JMIR Public Health Surveill. 2024 Sep 3;10:e53580. doi: 10.2196/53580. JMIR Public Health Surveill. 2024. PMID: 39226091 Free PMC article.
-
Impacts of COVID-19 on essential health services in Tigray, Northern Ethiopia: A pre-post study.PLoS One. 2021 Aug 27;16(8):e0256330. doi: 10.1371/journal.pone.0256330. eCollection 2021. PLoS One. 2021. PMID: 34449773 Free PMC article.
-
Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review.BMJ Open. 2021 Mar 16;11(3):e045343. doi: 10.1136/bmjopen-2020-045343. BMJ Open. 2021. PMID: 33727273 Free PMC article.
-
Early impact of the COVID-19 pandemic on in-person outpatient care utilisation: a rapid review.BMJ Open. 2022 Mar 3;12(3):e056086. doi: 10.1136/bmjopen-2021-056086. BMJ Open. 2022. PMID: 35241471 Free PMC article. Review.
Cited by
-
Occurrence and temporal changes of pharmaceuticals in the Warta River in Poland during and after the COVID-19 pandemic.Sci Rep. 2025 Aug 12;15(1):29451. doi: 10.1038/s41598-025-14568-x. Sci Rep. 2025. PMID: 40789900 Free PMC article.
References
-
- World Bank. World Development Report 2022: Finance for an Equitable Recovery, World Bank, Washington DC (2022). 10.1596/978-1-4648-1730-4.
-
- Violant-Holz V-G-J, AU-González-González MG, AU-Muñoz-Violant CS, Rodríguez SAU, AU-Sansano-Nadal MJ, Guerra-Balic OAU. MyriamTI-Psychological health and physical activity levels during the COVID-19 pandemic: A systematic review. Int. J. Environ. Res. Public. Health. 2020;17:24. doi: 10.3390/ijerph17249419. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical